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ABSTRACT 
Background: Studies show that repeated nicotine use associates with high alcohol 
consumption in humans, and that nicotine exposure sometimes increases alcohol 
consumption in animal models. However, the relative roles of genetic predisposition to high 
alcohol consumption, the alcohol drinking patterns, and the timing of nicotine exposure both 
with respect to alcohol drinking and developmental stage remain unclear.  The studies here 
manipulated all these variables, using mice selectively bred for differences in free-choice 
alcohol consumption to elucidate the role of genetics and nicotine exposure in alcohol 
consumption behaviors.  
Methods: In Experiments 1 and 2, we assessed the effects of repeated nicotine (0, 
0.5 or 1.5 mg/kg) injections immediately before binge-like (drinking-in-the-dark; Experiment 
1) or during free-choice alcohol access (Experiment 2) on these alcohol drinking behaviors 
(immediately after injections and during re-exposure to alcohol access 14 days later) in adult 
high- (HAP2) and low-alcohol preferring (LAP2) female mice (co-exposure model). In 
Experiments 3 and 4, we assessed the effects of repeated nicotine (0, 0.5 or 1.5 mg/kg) 
injections 14 days prior to binge-like and free-choice alcohol access on these alcohol 
drinking behaviors in adolescent HAP2 and LAP2 female mice (Experiment 3) or adult HAP2 
female mice (Experiment 4). 
Results: In Experiment 1, we found that repeated nicotine (0.5 and 1.5 mg/kg) and 
alcohol co-exposure significantly increased binge-like drinking behavior in HAP2 but not 
LAP2 mice during the re-exposure phase after a 14-day abstinence period. In Experiment 2, 
1.5 mg/kg nicotine injections significantly reduced free-choice alcohol intake and preference 
in the 3rd hour post-injection in HAP2 but not LAP2 mice. No significant effects of nicotine 
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treatment on binge-like or free-choice alcohol drinking were observed in Experiments 3 and 
4. 
Conclusions: These results show that the temporal parameters of nicotine and 
alcohol exposure, pattern of alcohol access, and genetic predisposition for alcohol 
preference influence nicotine’s effects on alcohol consumption. These findings in selectively 
bred mice suggest that humans with a genetic history of alcohol-use disorders may be more 
vulnerable to develop nicotine and alcohol co-use disorders.  
 
Keywords: Alcohol; Binge-Like Drinking; Genetics; Repeated Nicotine; Selectively-Bred 
Mice 
 
INTRODUCTION 
 Alcohol use disorders (AUDs) and tobacco use are highly co-morbid, with an 
estimated 80-90% of alcoholics being tobacco users (Miller and Gold, 1998). Conversely, 
tobacco users are more likely to consume alcohol, with an estimated 90% of tobacco users 
being regular alcohol drinkers (Keenan et al., 1990). Chronic tobacco and alcohol co-use 
leads to multiplicative negative consequences such as greater risk of developing cancers 
(Talamini et al., 1999) and greater relapse rates to alcohol drinking and tobacco use 
compared to the use of either drug alone (McKee and Weinberger, 2013). 
The factors that contribute to the high co-morbidity between AUDs and tobacco use 
are unclear. Epidemiological studies show that tobacco users find alcohol more reinforcing, 
consume more alcohol, and are more likely to engage in binge drinking than non-users 
(McKee et al., 2004). Studies have shown that the initiation of tobacco use may precede the 
initiation of alcohol use by months to years and that an earlier age of tobacco use initiation is 
associated with heavier future drinking (Chen et al., 2002; Grant, 1998). This suggests that 
tobacco use may act as a gateway to more severe alcohol drinking. However, some studies 
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show that the initiations of tobacco and alcohol use often overlap in many individuals and 
that individuals who co-use tobacco and alcohol tend to consume more alcohol (Grant, 
1998). Taken together, these epidemiological findings suggest that the effects of tobacco 
use alone and the effects of tobacco and alcohol co-use on future alcohol use severity are 
difficult to dissociate. Furthermore, epidemiological studies are correlational and do not show 
if tobacco use and/or tobacco and alcohol co-use has a causative effect on future alcohol 
use severity. 
Animal models have been useful in improving our understanding of the effects of 
nicotine on alcohol use. Studies in rodents have shown that repeated nicotine injections 
given just prior to alcohol access augment alcohol free-choice (FC) drinking or operant self-
administration (OSA) behaviors (Lê et al., 2003; Sajja and Rahman, 2012).  These findings 
suggest that repeated nicotine and alcohol co-exposure may increase alcohol reinforcement 
and drinking, consistent with the epidemiological findings reviewed above.  
Other studies in rodents have investigated the effects of repeated nicotine pre-
exposure in alcohol-naïve animals on subsequent (days to weeks) FC drinking or OSA. 
These studies were designed to mimic the order of exposure in many co-users of tobacco 
and alcohol, in which initiation of tobacco use precedes alcohol use and tobacco and alcohol 
co-use. The findings in this line of research have been varied, with reports of repeated 
nicotine pre-exposure having augmenting effects (Locker et al., 2016; Potthoff et al., 1983) 
or no effect (Kemppainen et al., 2009; Smith et al., 1999) on subsequent alcohol drinking or 
operant self-administration.  
In humans, the effects of tobacco use on alcohol intake may depend on the pattern of 
alcohol use behavior (Weitzman and Chen, 2005). Although a variety of alcohol use patterns 
are increased across-the-board in smokers compared to non-smokers, binge drinking, 
defined as a session of heavy drinking that produces blood alcohol concentrations (BACs) ≥ 
0.08 g/dL in 2h, is a more frequent form of drinking behavior than other patterns of drinking 
in smokers (McKee and Weinberger, 2013). In rodents, the effects of chronic nicotine on 
alcohol intake also seem to depend on the pattern of alcohol access. In mice, several days 
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of nicotine pre-exposure has been shown to increase binge-like drinking (Locker et al., 
2016), using a limited-access paradigm termed “drinking-in-the-dark” (DID), which produces 
BACs ≥ 0.08 g/dL in 2h in C57BL/6J inbred mice (Rhodes et al., 2007, 2005). However, the 
effects of repeated nicotine on FC drinking have not been explored in mice, perhaps 
because intake during FC drinking tends to result in relatively modest BACs below the 0.08 
g/dL level, even in the high-drinking C57BL/6J mouse (Matson and Grahame, 2013). In rats, 
repeated nicotine injections have been shown to increase (Blomqvist et al., 1996) or have no 
effect (Kemppainen et al., 2009) on FC drinking. However, the effects of chronic nicotine on 
binge-like drinking in rats are unknown, primarily due to a lack of reliable voluntary binge-like 
drinking procedures in rats (Hosová and Spear, 2017). To our knowledge, the effects of 
chronic nicotine on both FC and binge-like drinking have not been compared in the same 
species.  
Genetic factors contribute to the use and co-use of tobacco and alcohol in humans 
(Madden and Heath, 2002). Studies in animal models also show that common genetic 
factors contribute to alcohol- and nicotine-motivated behaviors. For example, selectively-
bred alcohol preferring (P) rats are more sensitive to nicotine reinforcement than non-
preferring (NP) and Wistar rats (Hauser et al., 2013; Lê et al., 2006). In addition, inbred 
strains of mice with a genetic predisposition for higher alcohol drinking also consume more 
nicotine (Robinson et al., 1996). However, the role of genetic predisposition in chronic 
nicotine’s effects on alcohol drinking requires further study to identify risk factors and 
targeted treatments for addiction.  
The current study had 4 experiments designed to address 3 main goals. The first 
goal was to explore the role of genetic propensity toward alcohol preference in nicotine-
alcohol interactions. We used mice selectively-bred (from the HS/IBG progenitor stock of 
heterogeneous mice) for high (HAP2) or low (LAP2) preference for alcohol in a continuous 
free-choice paradigm (Grahame et al., 1999; Oberlin et al., 2010). We hypothesized that 
HAP2 mice would be more sensitive to the effects of chronic nicotine on alcohol drinking 
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than LAP2 mice based on previous studies indicating genetic overlap between alcohol and 
nicotine-motivated behaviors (Hauser et al., 2013; Lê et al., 2006; Robinson et al., 1996).  
The second goal was to compare temporal parameters of repeated nicotine 
injections, either together with (co-exposure model), or prior to alcohol access (pre-exposure 
model), on binge-like and FC drinking behavior in mice. The binge-like drinking procedure 
used in the present study is a variant of the DID procedure mentioned previously (Rhodes et 
al., 2007).  For FC drinking, the procedure used in the present study has been shown to 
produce pharmacologically relevant (> 0.1 g/L) levels of alcohol drinking across the dark 
phase of the light-dark cycle in HAP2 mice (Matson and Grahame, 2013). Based on the 
studies reviewed above, we hypothesized that repeated nicotine injections concurrent with 
alcohol access (co-exposure) would produce a more robust augmentation of subsequent 
alcohol drinking than repeated nicotine injections prior to alcohol access (pre-exposure).  We 
also hypothesized that both co- and pre-exposure to repeated nicotine would have a greater 
effect on binge-like than free-choice drinking.  
The third goal was to compare age of nicotine pre-exposure (adolescent vs. adult) on 
subsequent binge-like and FC drinking in mice.  Adolescence is a unique period during 
which the brain is highly malleable by drugs (Spear, 2016), however, studies in adolescent 
rodents have indicated conflicting results. For example, in a study in which adolescent mice 
were given 22h per day access to nicotine drinking solution or water and 2h per day access 
to water (first 6d) and alcohol (subsequent 4d) for 10d, mice that were given nicotine solution 
showed greater alcohol intake (DID procedure) than mice in the water group (Locker et al., 
2016). In a rat study in which adolescent animals were given repeated nicotine or saline 
injections received FC access to alcohol in adulthood, no differences were observed 
between the nicotine and saline groups (Kemppainen et al., 2009).  Based on these studies 
and other findings that show that adolescents are more sensitive than adults to drugs’ long-
term effects (Spear, 2016), we hypothesized that nicotine pre-exposure during adolescence 
would produce a greater augmentation of alcohol drinking than pre-exposure during 
adulthood  and that this effect would be more evident in the DID procedure.  
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We focused our studies on female mice. A body of accumulating evidence suggests 
that females are more sensitive to nicotine’s effects than males, possibly due to hormonal 
differences between the sexes (Lynch et al., 2002). In humans, women tend to become 
nicotine-dependent faster and typically have lower success rates in smoking cessation than 
men (Pogun et al., 2017). Female C57BL/6J mice consume more nicotine, and show greater 
escalation of consumption over time and greater withdrawal symptoms, than male mice 
(Locklear et al., 2012). Female rats show greater motivation to self-administer nicotine than 
male rats (Donny et al., 2000). Additionally, the heritability of smoking has been shown to be 
higher in women than in men (Pogun et al., 2017) and alcohol intake is higher in female 
HAP2 and LAP2 mice than in males (Chester and Weera, 2017; Oberlin et al., 2010); thus, 
the use of females might improve the detection of nicotine-alcohol interactive effects in 
HAP2 and LAP2 mice.   
 
MATERIALS AND METHODS 
Subjects 
Experimentally-naïve female HAP and LAP mice from replicate line 2 (HAP2 and 
LAP2) were used in Experiments 1-3, and female HAP2 mice were used in Experiment 4. 
For Experiments 1, 2, and 3, mice were generated and tested at Purdue University using 
breeders obtained from the Indianapolis Alcohol Research Center (IARC). For Experiment 4, 
mice were generated and tested at the IARC. All mice were weaned between postnatal days 
(PND) 21-23 and housed with same sex littermates in clear polycarbonate cages (11.5 x 7.5 
x 5 in) in groups of 2-4 until the start of drinking procedures. During all drinking procedures, 
mice were singly-housed in a reversed 12:12 light-dark cycle and were given 14d to 
habituate to the housing environment before the start of drinking procedures. Mice had 
access to food and water ad libitum, except during DID (see below).  
Ages reported are ages at the start of experimental procedures (at the start of 
drinking in Experiments 1 and 2; at the start of injections in Experiments 3 and 4). In 
Experiment 1, HAP2 and LAP2 mice from generations 47 and 52 were between PND 106-
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149. In Experiment 2, HAP2 and LAP2 mice from generations 47 and 50 were between PND 
123-167. In Experiment 3, HAP2 and LAP2 mice from generation 47 were between PND 35-
38. In Experiment 4, HAP2 mice from generation 50 were between PND 87 and 93.  All 
procedures were approved by the Purdue University Animal Care and Use Committee.  
Drugs 
(-)-Nicotine base (Acros Organics, Geel, Belgium) was diluted in 0.9% saline. All 
nicotine doses are reported as free base. Alcohol was diluted from 95% alcohol (Koptec, 
King of Prussia, PA) to 10% (FC drinking) and 20% (DID) alcohol solutions in tap water. 
Nicotine doses were chosen based on prior studies that showed that nicotine injections 
altered alcohol drinking behaviors (e.g., Sajja and Rahman, 2012). All injections were given 
intraperitoneally at 10 mL/kg. Alcohol and water drinking bottles were always read on the 
cage to prevent spillage. 
Experiment 1: The effects of repeated nicotine injections on immediate binge-like 
alcohol drinking (DID) and on DID after a 14d abstinence period (re-exposure).  
Fig. 1A shows the timeline for the experimental procedures. Mice received 14d of 
habituation to single-housing and reversed light-dark cycle, 4d of DID acquisition, 3d of 
habituation (saline) injections, 10d of nicotine (0.5 or 1.5 mg/kg) or saline injections 
immediately before DID, a 14d abstinence period, and 2d of re-exposure to DID. Mice were 
assigned to experimental groups [0.0 (saline), 0.5, or 1.5 mg/kg nicotine] in a 
counterbalanced fashion based on their 2h alcohol intake on the 3rd day of habituation 
injections (Kasten et al., 2015). Nicotine injection procedures were modeled after the 
procedures of Sajja and Rahman (2012), who showed that repeated nicotine injections 
increased limited-access two-bottle choice drinking in C57BL/6J mice.  
For the DID procedure, standard water bottles were replaced with one bottle of 20% 
alcohol 3h into the dark cycle for 2h. Alcohol drinking bottles were made from 10-mL 
serological pipettes fitted with stainless steel sipper tubes. Meniscus readings were accurate 
to 0.1 mL. During habituation and nicotine/saline treatment, injections were given 
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immediately before alcohol presentation. Alcohol intakes were recorded at 1 and 2h post-
injection. Mice were weighed immediately before injections and received fresh alcohol daily 
during the DID procedure.  
After the last day of nicotine injections, mice from the second replication of this 
experiment were retained for 14d with access to water only (in regular water bottles) and 
then were re-exposed to 2d of DID to assess potential effects of the prior chronic nicotine 
and alcohol co-exposure on binge-like alcohol drinking after a 14d abstinence period. The 
rationale for this approach was to assess potential long-term effects of nicotine and alcohol 
co-exposure on binge-like drinking. Mice were given 14d of abstinence to prevent potentially 
confounding effects of acute alcohol and/or nicotine withdrawal.  
Experiment 2: The effects of repeated nicotine injections on immediate FC drinking 
and on FC drinking after a 14d abstinence period (re-exposure).  
Figure 2A shows the timeline for the experimental procedures. Mice received 14d of 
habituation to single-housing and reversed light-dark cycle, 14d of acquisition of FC drinking, 
3d of habituation (saline) injections, 9d of nicotine (0.5 or 1.5 mg/kg) or saline injections at 
3h into the dark cycle, a 14d abstinence period, and 6d of re-exposure to FC drinking. During 
the acquisition and re-exposure phases, mice were given one bottle of water and one bottle 
of 10% alcohol in 25-mL graduated plastic cylinders fitted with stainless steel sipper tubes. 
Meniscus readings were accurate to 0.5 mL. Alcohol and water were replaced and bottle 
positions were swapped every 2d to prevent development of side preference. After 14d of 
acquisition of FC drinking, 25-mL bottles were replaced by 10-mL bottles (described above) 
for the habituation and nicotine/saline injections phases of the experiment. Mice still had 
continuous access to alcohol and water, but intakes were recorded only at 1, 2, and 3h after 
habituation and nicotine/saline injections. Mice were assigned to experimental groups [0.0 
(saline), 0.5, or 1.5 mg/kg nicotine] in a counterbalanced fashion based on their 3h alcohol 
intake on the 3rd day of habituation injections. Mice then received 9 consecutive days of 
nicotine or saline injections at 3h into the dark cycle. During habituation and nicotine/saline 
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injections, drinking fluids were replaced daily and mice were weighed immediately before the 
start of the dark cycle. After the last day of nicotine injections, mice from the second 
replication of this experiment were retained for 14d with access to water only (in regular 
water bottles) and then re-exposed to 6d of FC drinking to assess potential effects of the 
prior chronic nicotine and alcohol co-exposure on FC drinking after a 14d abstinence period. 
Mice received 9 instead of 10d of injections as in Experiment 1 due to an injection error on 
the 10th day of the first replication of this experiment. Drinking data on this day was 
discarded and no mice from this replication were retained for the re-exposure.  Then, mice in 
the second replication of this experiment received 9 injections and were retained for the re-
exposure drinking test. 
Experiment 3: The effects of repeated nicotine injections during adolescence on FC 
drinking and DID in adulthood (HAP2 and LAP2 mice). 
Figure 3A shows the timeline for the experimental procedures. Group-housed 
adolescent mice received nicotine (0.5 or 1.5 mg/kg) or saline injections every other day 
beginning at PND 35-38 for 20d [10 injections total; based on the method of Kemppainen et 
al. (2009)]. Drug treatment groups were counterbalanced across mouse lines and cages. On 
the day after the final injection, mice were singly-housed in reversed 12:12 light-dark cycle 
and were habituated for 14d. On PND 69-72, regular water bottles were replaced by two 25-
mL bottles of 10% alcohol and water for 14d (FC drinking). Every 2d, drinking fluids were 
replaced with fresh alcohol or water, drinking bottle positions were swapped, and mice were 
weighed. Alcohol and water intakes were recorded daily for the first 6d and every 2d from 
days 8-14 of drinking.  
At the end of FC drinking, mice remained singly-housed with regular water bottles for 
14d, followed by 5d of exposure to the DID procedure. Mice were given 5d of DID instead of 
2 (Experiment 1) to assess if adolescent nicotine exposure produced any latent effects on 
DID. On each day, water bottles were replaced by one bottle of 20% alcohol 3h into the dark 
cycle for 2h. Alcohol intakes were recorded at the end of the 2h drinking session. 
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Experiment 4: The effects of repeated nicotine injections in adulthood on FC drinking 
and DID (HAP2 mice only). 
Figure 4A shows the timeline of experimental procedures. This experiment was 
conducted in Dr. Nicholas Grahame’s laboratory at IUPUI in a similar fashion to Experiment 
3 except only HAP2 adult mice were used because (1) untreated adult LAP mice usually do 
not drink enough alcohol in FC drinking to encounter its pharmacological effects (Oberlin et 
al., 2010).  Also, nicotine treatment did not alter alcohol intake in LAP2 mice in Experiments 
1-3 (see Results).  In addition, adult mice were singly housed during the injection period that 
started 20d prior to the start of FC alcohol drinking on PND 87-93 (recall that in Experiment 3 
mice needed to mature into adulthood before single housing and alcohol drinking exposure).     
During FC drinking, mice had access to 10% alcohol and water concurrently from 
either 25- or 50-mL bottles. Bottles were read daily for the first 9d, and every third day 
thereafter.  During the 2h of DID, mice had access to 20% alcohol from 10-mL serological 
pipettes fitted with stainless steel sipper tubes.  These drinking tubes were clamped to the 
stainless-steel wire cage lid. 
Statistical Analyses 
Alcohol intake was expressed as grams of alcohol per kilogram of body weight (g/kg).  
For FC drinking experiments, alcohol preference ratio [volume of alcohol intake (mL)/total 
fluid intake (mL)] was calculated. All data were analyzed using analysis of variance (ANOVA) 
in the Statistical Package for Social Sciences software (IBM Corporation, Armonk, NY). 
Omnibus ANOVA (between-subject factors: line and treatment group; within-subject factors: 
day and hour, where appropriate) with significant interactions were followed-up by lower 
order ANOVAs and Tukey’s post-hoc where appropriate. The significance level was set at p 
< 0.05. All data are shown as mean ± SEM. 
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RESULTS 
Experiment 1: The effects of chronic nicotine injections on immediate binge-like 
alcohol drinking (DID) and on DID after a 2-week abstinence period.  
DID during Acquisition and Habituation Injections: 
 Given that DID is not well-characterized in HAP and LAP mice, here we report DID in 
these mice during acquisition and habituation injections. Mean (± SEM) DID intake collapsed 
across the 4 acquisition days in HAP2 mice was 2.47 ± 0.13 (hour 1) and 1.76 ± 0.17 (hour 
2) and, in LAP2 mice, was 0.76 ± 0.09 (hour 1) and 0.82 ± 0.07 (hour 2).  Analysis of DID 
during acquisition [line (2) x day (4) x hour (2) ANOVA] yielded main effects of line [F(1,89) = 
107.1; p < 0.001; HAP2 > LAP2] and hour [F(1,89) = 8.7; p < 0.005] and a line x hour 
interaction [F(1,89) = 12.3; p = 0.001]. The interaction was due to significantly decreased 
alcohol intake in the second hour in HAP2 mice [Hour effect: F(1,44) = 12.9; p = 0.001] but 
not LAP2 mice.  
 Analysis of DID during habituation injections [line (2) x day (3) x hour (2) ANOVA] 
yielded a main effect of line [F(1,89) = 109.8; p < 0.001; HAP2 > LAP2] and a line x hour 
interaction [F(1,89) = 5.9; p < 0.05].  Mean (± SEM) DID intake collapsed across the 3 
habituation days in HAP2 mice was 1.61 ± 0.10 (hour 1) and 1.39 ± 0.10 (hour 2) and, in 
LAP2 mice, was 0.51 ± 0.06 (hour 1) and 0.64 ± 0.05 (hour 2).   
DID Immediately After Nicotine or Saline Injections: 
 Across 10d of nicotine/saline treatment, HAP2 mice in the 1.5 mg/kg nicotine group 
showed greater alcohol intake than HAP2 mice in the 0.5 mg/kg nicotine group in both hours 
1 and 2 across (Fig. 1B, D). An ANOVA of line (2) x treatment (3) x day (10) x hour (2) 
yielded significant main effects of line [F(1,85) = 69.7; p < 0.001], treatment [F(2,85) = 3.5; p 
< 0.05], day [F(9,765) = 4.0; p < 0.001], and hour [F(1,85) = 9.8; p < 0.005]. There were also 
significant day x line [F(9,765) = 4.6; p < 0.001], day x hour [F(9,765) = 3.3; p = 0.001], line x 
treatment [F(2,85) = 6.1; p < 0.005] and line x treatment x day x hour [F(18,765) = 1.7, p < 
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0.05] interactions.  This four-way interaction was further explored with line x treatment x day 
ANOVAs within each hour. 
The hour 1 ANOVA yielded significant main effects of line [F(1,85) = 44.9; p < 0.001; 
HAP2 > LAP2] and day [F(9,765) = 2.8, p < 0.005], and significant day x line [F(9,765) = 2.0; 
p < 0.05] and line x treatment [F(2,85) = 4.9; p = 0.01] interactions. The line x treatment 
interaction was due to a significant main effect of treatment in HAP2 mice only [F(2,42) = 
3.8, p < 0.05]. Tukey’s post-hoc showed that HAP2 mice that received 1.5 mg/kg nicotine 
injections showed greater hour 1 alcohol intake (average across 10d of treatment) than 
HAP2 mice that received 0.5 mg/kg nicotine injections (p < 0.05; Fig. 1B). An analysis of line 
within each treatment showed that HAP2 mice consumed more alcohol (average across 10d 
of treatment) than LAP2 mice in all treatment groups (ps < 0.05; Fig. 1B, C).  
The hour 2 ANOVA (line x treatment x day) yielded significant main effects of line 
[F(1,85) = 67.1; p < 0.001], treatment [F(2,85) = 3.1; p < 0.05], and day [F(9,765) = 4.6; p < 
0.001], and significant day x line [F(9,765) = 4.5; p < 0.001] and line x treatment [F(2,85) = 
4.6; p < 0.05] interactions. The day x line interaction was due to a significant effect of day in 
HAP2 mice only [F(9,396) = 5.2; p < 0.001]. The line x treatment interaction was due to a 
significant main effect of treatment in HAP2 mice only (p < 0.05). Tukey’s post-hoc showed 
that HAP2 mice that received 1.5 mg/kg nicotine injections consumed more alcohol (average 
across 10d of treatment) than HAP2 mice that received 0.5 mg/kg nicotine injections (p < 
0.05; Fig. 1D). An analysis of line within each treatment showed that HAP2 mice showed 
greater alcohol intake than LAP2 mice in all treatment groups (ps < 0.005; Fig. 1D, E).  
 Given that it was previously found that a single acute injection of nicotine (0.5 mg/kg) 
decreased alcohol intake in C57BL/6J mice in a DID procedure (Hendrickson et al., 2009), 
we also performed a within-subjects analysis comparing intake at both hours on the last 
habituation day to intake at both hours after the first nicotine/saline treatments (day 1) as 
another way to assess initial sensitivity to nicotine’s effects on DID. We found that a 0.5 
mg/kg nicotine injection on the first day significantly reduced hour 1 alcohol intake in HAP2 
mice (Fig. 1B). ANOVA on hour 1 data [line (2) x treatment (3) x day (2)] yielded significant 
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main effects of line [F(1,85) = 41.5, p <0.001] and day [F(1,85) = 17.2, p <0.001] and a line x 
treatment x day interaction [F(2,85) = 3.1, p < 0.05]. Follow up ANOVAs indicated a 
treatment x day interaction in HAP2 only [F(2,42) = 3.7, p < 0.05].  One way ANOVA of 
treatment within each day in HAP2 mice indicated a treatment effect on the first day of 
treatment [F(2,42) = 4.5, p < 0.05] and Tukey’s post-hoc analyses showed that alcohol 
intake in the 0.5 mg/kg nicotine group was significantly lower than the saline group (p < 0.05; 
Fig 1B). 
ANOVA on hour 2 data [line (2) x treatment (3) x day (2)] yielded a significant main 
effect of line only [F(1,85) = 79.2, p < 0.001; HAP2 > LAP2; Fig. 1D,E]. 
DID After 2-week Abstinence Period (Re-exposure): 
 During re-exposure to DID following a 2-week abstinence period, HAP2 mice in the 
nicotine treatment groups generally showed greater hour 1 alcohol intake than HAP2 mice in 
the saline group. On day 1 of re-exposure, HAP2 mice in the 1.5 mg/kg nicotine group 
showed greater hour 1 alcohol intake than HAP2 mice in the saline and 0.5 mg/kg nicotine 
groups. On day 2 of re-exposure, HAP2 mice in the 0.5 mg/kg nicotine group showed 
greater hour 1 alcohol intake than HAP2 mice in the saline group (Fig. 1B). Because we 
observed hour-dependent effects above, we analyzed alcohol intake in hours 1 and 2 
separately. An ANOVA of line (2) x treatment (3) x day (2) on hour 1 alcohol intake during 
DID re-exposure yielded significant main effects of line [F(1,38) = 116.7; p < 0.001], 
treatment [F(2,38) = 5.3; p < 0.01], and day [F(1,38) = 26.2; p < 0.001], and a significant day 
x line x treatment interaction [F(2,38) = 5.0; p < 0.05]. Follow up ANOVAs indicated a 
significant treatment x day interaction [F(2,18) = 6.6; p < 0.01] in HAP2 mice only. Follow-up 
analyses of treatment within each day yielded significant treatment effects on both days 1 (p 
< 0.05) and 2 (p < 0.01). On day 1 of re-exposure, Tukey’s post-hoc analyses showed that 
HAP2 mice that previously received 1.5 mg/kg nicotine injections consumed more alcohol 
than HAP2 mice that received saline (p = 0.06) or 0.5 mg/kg nicotine (p = 0.05). On day 2 of 
re-exposure, Tukey’s post-hoc showed that HAP2 mice that received 0.5 mg/kg nicotine 
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injections consumed significantly more alcohol than HAP2 mice that received saline (p < 
0.01). The difference in alcohol intake between the saline and 1.5 mg/kg nicotine groups was 
not significant (p = 0.09).  
For hour 2 data, an ANOVA of line x treatment x day yielded significant main effects 
of line [F(1,38) = 21.6; p < 0.001; HAP2 > LAP2] and treatment [F(2,38) = 4.1; p < 0.05]. 
Tukey’s post-hoc for treatment showed that mice in the 1.5 mg/kg nicotine group showed 
lower alcohol intake than mice in the saline group in hour 2 of re-exposure (p < 0.05; 
collapsed across line and day; Fig. 1D, E).  
Experiment 2: The effects of repeated nicotine injections on immediate FC drinking 
and on FC drinking after a 2-week abstinence period (re-exposure). 
FC Drinking Immediately After Nicotine or Saline Injections: 
 Across 9d of nicotine/saline treatment, HAP2 mice that received 1.5 mg/kg nicotine 
injections showed lower hour 3 alcohol intake and preference compared to HAP2 mice in the 
saline and 0.5 mg/kg nicotine groups (Fig. 2D, F). ANOVAs of line (2) x treatment (3) x hour 
(3) x day (9) on alcohol intake and preference yielded significant main effects of line [F(1,85) 
= 206.2 and 461.3, on intake and preference, respectively; ps < 0.001; HAP2>LAP2] and a 
significant line x treatment x hour interaction [F(4,170) = 6.0 and 4.6 for intake and 
preference, respectively; ps < 0.001 and 0.005]. Since there was no four-way interaction with 
day, the alcohol intake and preference data were analyzed collapsed across days. Follow-up 
analyses of line x treatment within each hour (1, 2, and 3) post-injection yielded significant 
main effects of line (HAP2 > LAP2) at all 3 time points [F(1,85) = 89.7, 206.0, 143.1 on 
intake, and 237.4, 248.5, 345.9 on preference; ps < 0.001; Fig. 2B-G]. At hour 3 only, there 
was a significant main effect of treatment [F(2,85) = 3.4; p < 0.05] for alcohol intake and 
significant line x treatment interactions for alcohol intake and preference [F(2,85) = 5.7 and 
7.7; ps = 0.005 and < 0.001, respectively]. Follow-up one-way ANOVA of treatment on hour 
3 alcohol intake and preference within each line yielded significant effects of treatment only 
in HAP2 mice [F(2,40) = 4.0 and 5.4, ps < 0.05 and 0.01, respectively]. Tukey’s post-hoc 
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analysis showed that HAP2 mice that received 1.5 mg/kg nicotine showed lower alcohol 
intake and preference than HAP2 mice that received 0.0 and 0.5 mg/kg nicotine in the 3rd 
hour post-injection (p < 0.05; Fig. 2D, G). Analyses of line within each treatment showed that 
HAP2 mice showed significantly greater alcohol intake than LAP2 mice at all treatments (ps 
< 0.05; Fig. 2B-G).  
FC Drinking After 2-week Abstinence Period (Re-exposure): 
 Nicotine treatment did not significantly affect alcohol intake or preference during re-
exposure to FC drinking following a 2-week abstinence period (Fig. 2H, I). ANOVAs of line 
(2) x treatment (3) x day (3) on alcohol intake and preference during re-exposure to FC 
drinking yielded significant main effects of line [F(1,40) = 636.0 and 662.4, on intake and 
preference, respectively; ps < 0.001; HAP2 > LAP2] and a significant main effect of 
treatment [F(2,40) = 4.8; p < 0.05] on alcohol intake. Tukey’s post-hoc analysis of treatment 
on alcohol intake collapsed by line did not yield any significant effects. However, the main 
effect of treatment appears to be due to increased alcohol intake in mice that received 
chronic nicotine and alcohol co-exposure.  There were no significant effects of day on 
alcohol intake or preference (Fig. 2H, I). 
Experiment 3: The effects of chronic nicotine injections in adolescent HAP2 and LAP2 
mice on subsequent (adult) FC drinking and DID. 
Nicotine treatment in HAP2 and LAP2 mice during adolescence did not affect alcohol 
intake in adulthood, as measured by FC drinking and DID (Fig. 3B-D). An ANOVA of line (2) 
x treatment (3) x day (10) on FC alcohol intake and preference yielded significant main 
effects of line [F(1,66) = 1314.6 and 621.8, on intake and preference, respectively; ps < 
0.001; HAP2 > LAP2; Fig. 3B, C]. An ANOVA of line (2) x treatment (3) x day (5) on alcohol 
intake during the 5 days of DID also yielded a significant main effect of line [F(1,65) = 166.5; 
p < 0.001; HAP2 > LAP2; Fig. 3D]. 
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Experiment 4: The effects of chronic nicotine injections in adult HAP2 mice on 
subsequent FC drinking and DID. 
 Nicotine treatment in adult HAP2 and LAP2 mice did not affect subsequent alcohol 
intake, as measured by FC drinking and DID (Fig. 4B-D). An ANOVA of treatment (3) x day 
(9) on FC alcohol intake and preference did not show any main effects or interaction (Fig. 
4B, C). An ANOVA of treatment (3) x day (4) on DID alcohol intake showed a main effect of 
day only [F(3, 48) = 3.4, p < 0.05], driven by generally declining alcohol intake over days 
(Fig. 4D).   
 
DISCUSSION 
Overall, we report that the effects of repeated nicotine injections on alcohol intake are 
dependent on temporal parameters, alcohol drinking paradigm, and genetic predisposition 
for alcohol preference. One main goal of this study was to compare the effects of repeated 
nicotine co-exposure on alcohol consumption (DID in Experiment 1 and FC in Experiment 2) 
with the effects of repeated nicotine pre-exposure in the absence of concurrent alcohol 
access (Experiments 3 and 4), using both binge-like and FC drinking procedures. We found 
that repeated nicotine and binge-like alcohol co-exposure increased binge-like alcohol intake 
in HAP2 mice during re-exposure to DID after a 2-week abstinence period (Experiment 1). 
However, repeated nicotine and FC alcohol co-exposure did not affect FC drinking after a 
14d abstinence period (Experiment 2). Repeated nicotine pre-exposure alone during 
adolescence (Experiment 3) or adulthood (Experiment 4) did not produce any effects on 
subsequent FC or binge-like drinking. 
During the nicotine/saline treatment phase of Experiment 1, acute injection of 
nicotine (0.5 mg/kg) on day 1 decreased DID alcohol intake during hour 1 in HAP2 mice 
only. This finding is similar to those of Hendrickson and colleagues (2009), who found that a 
single injection of nicotine (0.5 mg/kg) decreased hour 1 DID alcohol intake in C57BL/6J 
mice. A possible explanation offered by the authors was that an acute nicotine pretreatment 
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may have desensitized nicotinic acetylcholine receptors (nAChRs), which are important 
mediators of alcohol’s reinforcing effects (Hendrickson et al., 2013). Overall, averaged 
across 10d of nicotine/saline treatments, HAP2 mice that received 1.5 mg/kg nicotine had 
higher alcohol intake than mice that received 0.5 mg/kg nicotine injections in both hours 1 
and 2 post-injection (Fig. 1B, D). The reason for this outcome was due to the fact that 
alcohol intake in the 0.5 mg/kg group remained relatively low whereas intake in the 1.5 
mg/kg group tended to increase across the 10d of treatment (analyses indicated that neither 
nicotine group significantly differed from saline). One possible explanation for this finding is 
that the different doses of nicotine may have caused different adaptations of nAChRs, such 
as upregulation/downregulation of different nAChR subtypes and/or alterations of subunit 
composition (Govind et al., 2012, 2009). Previous studies have shown that different nicotine 
treatment doses may result in different nAChR-mediated motivation-related outcomes such 
as dopamine neuron firing (Besson et al., 2007; Tolu et al., 2013).  
After 2 weeks of forced abstinence, in the first hour only on day 1 of re-exposure to 
DID, HAP2 mice with a history of 1.5 mg/kg nicotine treatment showed significantly elevated 
alcohol intake (compared to the saline group and 0.5 mg/kg group, which did not differ from 
saline). In the first hour only on day 2 of re-exposure to DID, all groups showed increased 
intake but intake in the nicotine-treated groups were higher than the saline-treated group, 
with a significant difference between the 0.5 mg/kg nicotine vs. saline group. Interestingly, 
nicotine-treated groups in both lines (main effect of treatment) showed reduced alcohol 
intake in hour 2 of DID (collapsed across both re-exposure days). This intake behavior may 
be similar to the ‘front-loading’ phenomenon observed following weeks of daily DID access in 
C57BL/6J mice.  These animals shift overall intake to the beginning of the 2h daily access 
period, which may represent increased motivation and/or compulsion to consume alcohol 
(Linsenbardt and Boehm, 2014). This interpretation is consistent with a recent finding in rats 
that chronic nicotine in alcohol dependent rats increased motivation and compulsion to seek 
alcohol in an OSA paradigm (Leão et al., 2015), and supports studies in humans that show 
that binge drinking is highly associated with tobacco use (McKee and Weinberger, 2013). 
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However, a subsequent study by (Linsenbardt and Boehm, 2015) reported that the “front-
loading” effect was not specific to alcohol because it was also observed in HAP1 mice that 
had repeated DID exposures to water only. Additional studies are necessary to characterize 
the specificity of the nicotine pre-exposure effect on DID alcohol drinking in HAP2 and HAP3 
mice using other reinforcers like water and saccharin.   
Nicotine injections produced some acute effects on FC drinking in Experiment 2. 
HAP2 mice that received 1.5 mg/kg nicotine showed lower alcohol intake and preference 
than controls in the 3rd hour post-injection. This is a novel finding because previous studies 
of immediate nicotine effects on alcohol drinking in mice have not measured alcohol intake 
beyond 2h post-injection (Sajja and Rahman, 2012). The decreased alcohol intake in HAP2 
mice is consistent with Sharpe and Samson (2002), in which repeated nicotine injections 
immediately prior to alcohol OSA decreased both alcohol seeking and consumption in rats. 
The time-dependent effects of nicotine in this experiment are also reminiscent of studies in 
rats which found that an acute nicotine injection immediately prior to alcohol OSA decreased 
responding, but an acute nicotine injection 3-4h prior to alcohol OSA increased responding 
(Doyon et al., 2013a; Hauser et al., 2012).  
Given the short half-life of nicotine in mice, it is important to note that the attenuating 
effect of nicotine on alcohol consumption 3h after injection observed in Experiment 2 may 
not be a direct effect caused by nicotine itself but rather by nicotine’s primary metabolite, 
cotinine, which has a much longer half-life than nicotine (up to 1h in mice) and is available in 
high concentrations in the brain (Siu and Tyndale, 2007). Cotinine has been shown to 
modulate nAChRs (Terry et al., 2015), promote striatal dopamine release (Dwoskin et al., 
1999), and decrease impulsive- and compulsive-like behavior (Terry et al., 2012). Given that 
alcohol consumption is modulated by nAChRs and the striatal dopamine system 
(Hendrickson et al., 2013), and that high alcohol consumption is associated with high 
impulsivity (Oberlin and Grahame, 2009), these effects of cotinine may reduce alcohol 
consumption.  
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Assuming that the mice in this study metabolized alcohol at a rate recorded 
previously (0.85-0.90 g/kg/hr; Chester and Barrenha, 2007), DID alcohol intake may have 
produced pharmacologically-relevant BACs in LAP2 mice. Thus, the DID procedure may be 
a particularly useful model for exploring mechanisms regulating alcohol drinking in people 
without a genetic family history of AUDs. Although the DID procedure appears to have 
increased alcohol intake in LAP2 mice, HAP2 mice still drank double the amount of LAP2 
mice. Similar findings in HAP1 and LAP1 mice tested in a DID procedure were previously 
reported (Crabbe et al., 2011), showing that, not surprisingly, genetic mechanisms that 
underlie FC alcohol drinking also influence binge-like drinking. 
Several other mechanisms may underlie nicotine’s effects on alcohol drinking in 
HAP2 mice. Repeated nicotine exposure has been shown to produce cross-tolerance to 
alcohol and increased self-administration of alcohol, which can be mediated by metabolic 
enzymes and/or by alterations in synaptic plasticity in the brain (Abburi et al., 2016; Florek et 
al., 2015). As mentioned above, a study recently showed that concurrent nicotine and 
alcohol exposure increases motivation for alcohol self-administration and compulsive-like 
drinking in rats. These behavioral findings were accompanied with nAChR-dependent 
activation of neuronal ensembles in stress-related brain areas such as central amygdala, 
dorsomedial prefrontal cortex, and bed nucleus of the stria terminalis (Leão et al., 2015). The 
stress system, including the glucocorticoid system, plays an important role in nicotine’s 
augmenting effects on alcohol self-administration (Doyon et al., 2013) and in the 
development of compulsive-like alcohol self-administration (Vendruscolo et al., 2012).  
HAP and LAP mouse lines differ in behavioral and hormonal response to stressors 
(Breit and Chester, 2016; Chester et al., 2014).  Notably, we have shown a strong inverse 
genetic correlation between propensity for high alcohol preference and corticosterone levels 
after footshock and conditioned fear-related stimuli (LAP1/2 > HAP1/2 lines; Chester et al., 
2014). Nicotine, like alcohol and other drugs of abuse, is a chemical stressor that stimulates 
the release of corticosterone (Armario, 2010) and it is possible that line differences in stress 
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system responsivity to nicotine partly contribute to the observed line differences in sensitivity 
to nicotine’s effect on alcohol drinking behavior.  
Exposure to nicotine has been shown to produce cross-sensitization to alcohol’s 
rewarding effects (Biala and Budzynska, 2008), perhaps by sensitizing midbrain dopamine 
neurons to alcohol’s stimulating effects (Ding et al., 2012). The delayed nature of nicotine’s 
effects on alcohol drinking suggests that alterations in gene expression may be involved. 
Nicotine exposure can alter epigenetic mechanisms that regulate a variety of genes, 
including the addiction-related FosB gene (Nestler, 2001). One study showed that nicotine 
exposure increased the ability of cocaine to increase FosB expression through inhibition of 
histone deacetylase (Levine et al., 2011). Given that increased FosB expression increases 
the rewarding effects of drugs (Nestler, 2001), alterations in epigenetic regulation of the 
FosB gene by nicotine and alcohol exposure may contribute to the increased alcohol 
drinking seen in Experiment 1. For further discussion on the molecular sites of nicotine-
alcohol interactions, please refer to the following excellent reviews: Hendrickson et al., 2009; 
Tarren and Bartlett, 2017. 
Finally, another goal of the present study was to assess the effects of repeated 
nicotine pre-exposure during adolescence vs. adulthood on alcohol drinking. We did not find 
any effects of repeated nicotine pre-exposure (injections) during adolescence (Experiment 3) 
or adulthood (Experiment 4) on either FC or binge-like drinking. This supports previous 
findings in rats (Kemppainen et al., 2009), but is inconsistent with the findings of Locker et al. 
(2016) in mice. Nicotine was injected by experimenters in the present study as well as in rats 
(Kemppainen et al., 2009), who reported similar findings. On the other hand, mice received 
nicotine in their drinking water in Locker et al. (2016). These differences in the mode of 
nicotine delivery may have produced different biological consequences that, in turn, 
produced different influences on alcohol drinking behaviors. For example, the chronic nature 
of nicotine access (22h/d) in the study by Locker et al. (2016) may have resulted in a 
different pattern and/or level of nAChR upregulation than repeated nicotine injections. A 
study previously showed that chronic nicotine delivery via osmotic minipumps results in 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
greater upregulation of nAChRs than repeated nicotine injections (Ulrich et al., 1997). 
Secondly, there was a gap of at least 14d between the end of repeated nicotine exposure 
and the start of alcohol drinking procedures in the present study and in Kemppainen et al. 
(2009), which may have permitted the reversal of neuroadaptations produced by chronic 
nicotine that may have altered subsequent alcohol drinking. In comparison, there was an 
overlap of 4d between chronic nicotine pre-exposure in the drinking water and introduction of 
alcohol-containing bottles for 2h in Locker et al. (2016). Further studies are needed to 
address these speculations.  
It is important to note that the experiments in the present study were conducted in 
female mice, which often show greater responses to nicotine than males (see Introduction); 
however, sex effects may be dependent on genotype (Bernardi et al., 2016). Given the sex 
differences in nicotine sensitivity (see review by Pogun et al., 2017) and in nicotine-alcohol 
interactions (see review by Adams, 2017), future studies should include male subjects for 
comparison. In addition, we plan to test the effects of adolescent alcohol exposure on 
subsequent nicotine responses in HAP/LAP lines to shed additional light on age-related and 
genetic vulnerabilities associated with co-abuse of alcohol and nicotine. Finally, future work 
should build upon the current findings by examining nicotine-alcohol interactions in the 
replicate 3 HAP/LAP selected lines to further support conclusions that nicotine’s effects on 
alcohol-drinking behaviors are regulated by genes selected for high or low alcohol 
preference. In summary, our results indicate that co-exposure to repeated nicotine injections 
and alcohol, but not repeated pre-exposure to nicotine alone (in adolescents or adults), 
increases binge-like alcohol intake in HAP2 but not LAP2 mice after a period of abstinence. 
These findings in selected mouse lines indicate that nicotine’s effects on motivation to binge 
drink alcohol depend on genetic predisposition toward alcohol preference. Chronic binge 
drinking and tobacco use in humans with a genetic history of AUDs may lead to an 
escalation of subsequent binge drinking and more severe alcohol-related problems.  
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FIGURE LEGENDS 
Figure 1. The effects of repeated nicotine injections on immediate binge-like alcohol 
drinking (DID) and on DID after a 14d abstinence period (re-exposure). (A) Timeline 
schematic for Experiment 1. Mice were given alcohol access 2h every day except during the 
14d abstinence period. (B – E) DID immediately after nicotine or saline injections. a HAP2 
mice that received 1.5 mg/kg nicotine injections showed greater average (across 10d) 
alcohol intake than mice that received 0.5 mg/kg nicotine injections (p <0.05). b HAP2 mice 
that received 0.5 mg/kg nicotine showed significantly lower alcohol intake than mice that 
received saline on day 1 of nicotine/saline injections. c HAP2 mice that received 1.5 mg/kg 
nicotine injections showed greater alcohol intake than mice that received 0.5 mg/kg (p = 
0.05) nicotine injections on the first day of DID (hour 1) following a 2-week abstinence 
period. d HAP2 mice that received 0.5 mg/kg nicotine injections showed greater alcohol 
intake than mice that received saline injections on the second day of DID (hour 1) following a 
14d abstinence period (p < 0.01). N’s = 13-16/line/treatment group (5-8/line/treatment group 
for re-exposure phase).  
Figure 2. The effects of repeated nicotine injections on immediate FC drinking and on 
FC drinking after a 14d abstinence period (re-exposure). (A) Timeline schematic for 
Experiment 2. Mice were given FC alcohol access throughout the experiment except during 
the 14d abstinence period. (B – D) Immediate post-nicotine alcohol intake and (E – G) 
alcohol preference over 9d of FC drinking. HAP2 mice in the 1.5 mg/kg nicotine group 
showed significantly lower alcohol intake (D) and preference (G) than HAP2 mice in the 0.0 
or 0.5 mg/kg nicotine groups in hour 3 post-injection. (H) Alcohol intake and (I) preference 
over 6d of FC drinking after a 14d abstinence period (re-exposure phase). There were no 
significant effects of treatment on re-exposure FC alcohol intake or preference. All data are 
presented collapsed by day as there were no significant effects of day. *p < 0.05; (B – G) N 
= 14-17/line/treatment group; (H, I) N = 7-8/line/treatment group. 
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Figure 3. The effects of repeated nicotine injections during adolescence on FC 
drinking and DID in adulthood (HAP2 and LAP2 mice). (A) Timeline schematic for 
Experiment 3. Mice were given alcohol access only during FC drinking and DID. (B) FC 
alcohol intake and (C) preference over 14d. (D) DID alcohol intake over 5d. All data are 
presented collapsed by day as there were no significant effects of day. N = 11-
12/line/treatment group.  
Figure 4. The effects of repeated nicotine injections in adulthood on alcohol FC 
drinking and DID (HAP2 mice only). (A) Timeline schematic for Experiment 4. Mice were 
given alcohol access only during FC drinking and DID. (B) FC alcohol intake and (C) 
preference over 14d. (D) DID alcohol intake over 5d. Chronic nicotine pre-exposure had no 
effect on FC drinking and DID in adult HAP2 mice. All data are presented collapsed by day 
as there were no significant effects of day. N = 11-14/treatment group.  
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